Drug
Flulaval Quadrivalent
Flulaval Quadrivalent: highest development phase Phase 2, developed by GlaxoSmithKline. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| FluLaval® Quadrivalent NCT01974895 | Phase 2 | Influenza |
Latest
No recent events.
Follow Flulaval Quadrivalent on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.